1. Home
  2. ONL vs PMN Comparison

ONL vs PMN Comparison

Compare ONL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.99

Market Cap

141.5M

Sector

Real Estate

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$10.97

Market Cap

115.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
PMN
Founded
2021
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
115.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ONL
PMN
Price
$2.99
$10.97
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$3.00
$42.67
AVG Volume (30 Days)
334.5K
25.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,647,000.00
N/A
Revenue This Year
$4.10
N/A
Revenue Next Year
$3.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.86
$0.29
52 Week High
$3.04
$27.40

Technical Indicators

Market Signals
Indicator
ONL
PMN
Relative Strength Index (RSI) 64.11 46.21
Support Level $2.81 $10.55
Resistance Level N/A $13.80
Average True Range (ATR) 0.10 0.50
MACD -0.02 0.16
Stochastic Oscillator 78.26 63.84

Price Performance

Historical Comparison
ONL
PMN

About ONL Orion Office REIT Inc.

Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: